Protection against experimental cholera by oral or parenteral immunization
- PMID: 546789
- PMCID: PMC414658
- DOI: 10.1128/iai.26.2.594-598.1979
Protection against experimental cholera by oral or parenteral immunization
Abstract
Comparisons were made between the antigenic potency and protective capacity of several cholera toxin derivatives. Rabbits were immunized parenterally with 50 microgram of cholera toxin, A subunit, B subunit, procholeragenoid, or Wyeth glutaraldehyde toxoid 20101. Examination of the antibody response curves revealed that cholera toxin elicited serum antitoxin responses that rose more quickly than in the subunit-immunized animals; however, antitoxin levels were of the same magnitude after 10 weeks. Parenteral immunization with procholeragenoid evoked antibody titers that were similar to the toxin, whereas Wyeth toxoid yielded only one-tenth the level of antitoxin. Oral immunization with procholeragenoid as well as Wyeth toxoid resulted in lower serum antitoxin titers than that achieved with parenteral immunization, despite the oral administration of 10 times the parenteral dose. Analysis of protection against live-cell challenge revealed that parenteral administration of procholeragenoid provided the best protection against fluid accumulation. Oral immunization with procholeragenoid also was very effective, whereas oral immunization with B subunit or Wyeth toxoid resulted in minimal protection. Also, the A subunit provided surprisingly more protection than did cholera toxin.
Similar articles
-
Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.Infect Immun. 1979 Nov;26(2):528-33. doi: 10.1128/iai.26.2.528-533.1979. Infect Immun. 1979. PMID: 546785 Free PMC article.
-
Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.Infect Immun. 1983 Jun;40(3):1112-8. doi: 10.1128/iai.40.3.1112-1118.1983. Infect Immun. 1983. PMID: 6602094 Free PMC article.
-
Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.Infect Immun. 1978 Jul;21(1):185-93. doi: 10.1128/iai.21.1.185-193.1978. Infect Immun. 1978. PMID: 711314 Free PMC article.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Cholera vaccines.Clin Infect Dis. 2000 Aug;31(2):561-5. doi: 10.1086/313951. Epub 2000 Sep 7. Clin Infect Dis. 2000. PMID: 10987721 Review.
Cited by
-
Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.Infect Immun. 1981 Jan;31(1):144-50. doi: 10.1128/iai.31.1.144-150.1981. Infect Immun. 1981. PMID: 7011990 Free PMC article.
-
Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.Infect Immun. 1993 Dec;61(12):5271-8. doi: 10.1128/iai.61.12.5271-5278.1993. Infect Immun. 1993. PMID: 7693598 Free PMC article.
-
Preparation of procoligenoids from Escherichia coli heat-labile enterotoxins.Infect Immun. 1984 Aug;45(2):518-21. doi: 10.1128/iai.45.2.518-521.1984. Infect Immun. 1984. PMID: 6378800 Free PMC article.
-
Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera.PLoS One. 2013;8(2):e57269. doi: 10.1371/journal.pone.0057269. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23468950 Free PMC article.
-
Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.Infect Immun. 1989 Jul;57(7):1942-5. doi: 10.1128/iai.57.7.1942-1945.1989. Infect Immun. 1989. PMID: 2731977 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources